Dr. Sreedhar A. Mandayam, MD

  • Houston, TX
  • Nephrologist
NPI1225051048PAC ID7911901756
Medicare services, 2024
792
Medicare patients, 2024
345
Part D claims, 2024
334
Publications
45
Clinical trials
5
Practice address
1515 Holcombe Blvd, Houston, TX 77030
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Find Dr. Mandayam's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Sreedhar A. Mandayam is a nephrologist in Houston, Texas

Dr. Mandayam practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Mandayam's NPI, 1225051048, was assigned on July 25, 2006. Dr. Mandayam graduated from Bangalore Medical College in 1995. Dr. Mandayam's Texas license number on file is N3861.

NPI and contact details
Medicare PAC ID
7911901756
NPI enumeration date
July 25, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
57
Medical school graduation
1995

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Sreedhar A. Mandayam practices at The University of Texas MD Anderson Cancer Center in Houston, Texas

Dr. Mandayam's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Source: Dmand AI Affiliation Data

Dr. Sreedhar A. Mandayam is affiliated with 1 site of care and 3 medical groups

Dr. Mandayam's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service. Dmand AI also links Dr. Mandayam to 2 more medical groups, each named with a free account.

See all 4 affiliations for Dr. Mandayam

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Sreedhar A. Mandayam's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mandayam practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
The University of Texas MD Anderson Cancer CenterAvailable with a free account
+2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Mandayam practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across The University of Texas System and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Sreedhar A. Mandayam is one of 1,045 nephrologists in Texas

Nephrology is Dr. Mandayam's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Mandayam is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Mandayam's licenses on file in 10 states: Texas, Florida, Tennessee, Mississippi, Oklahoma, Washington, Alabama, Arizona, Georgia and Louisiana.

Specialties and state licenses

  • Nephrology, TexasPrimaryLicense N3861 · 2009 to 2025 · taxonomy 207RN0300X
  • Florida licenseSince 2021
  • Tennessee license2023 to 2027
  • Mississippi license2024 to 2026
  • Oklahoma license2020 to 2026
  • Washington license2023 to 2026
  • Alabama license2024 to 2025
  • Arizona license2023 to 2025
  • Georgia license2024 to 2025
  • Louisiana license2023 to 2025

Clinical focus

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and kidney disease among the conditions Dr. Mandayam treats.

Nephrologists near Dr. Mandayam

Counts of nephrologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Sreedhar A. Mandayam billed Medicare for 792 services in 2024

CMS data shows 792 Medicare services from Dr. Mandayam across 7 procedure codes in 2024, for 345 Medicare patients. Medicare paid $85,521 for them.

Medicare services, 2024792
Medicare patients345
Paid by Medicare$85,521
Procedure codes7

Dr. Mandayam's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 7152024: 713No change
Tests and treatments
2023: 732024: 798%

Where Dr. Mandayam's Medicare services took place, 2024

  • In an office466%
  • In a facility74694%

Dr. Mandayam compared with the Texas median for nephrologists, 2024

  • Dr. Mandayam
  • Texas median
Medicare services
792vs 1,04824% below
Medicare patients
345vs 27725% above
Part D claims
193vs 75875% below

Medians across 1,017 nephrologists in Texas with Dmand AI profiles that report each measure.

Dr. Mandayam's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Mandayam

Need commercial claims for Dr. Mandayam?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mandayam and other nephrologists in Texas.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Sreedhar A. Mandayam treated 345 Medicare patients in 2024, average age 71

CMS counts 345 Medicare patients who saw Dr. Mandayam in 2024. The largest group is 65 to 74, with 172 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 8% are also on Medicaid. Their average risk score is 4.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mandayam's median patient age at 71, with 37% women.

Medicare patients, 2024345
Average age71
Average risk score4.05
Also on Medicaid8%

Dr. Mandayam's Medicare patients by age, 2024

Dr. Mandayam's Medicare patients by sex, 2024

  • Women12235%
  • Men22365%

Chronic conditions among Dr. Mandayam's Medicare patients, 2024

  1. Chronic kidney disease75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Cancer52%
  5. Arthritis51%
  6. Diabetes50%
  7. Ischemic heart disease50%
  8. Heart failure43%

Share of Medicare patients with each condition. A patient can have several.

Dr. Mandayam's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 71

Patient panel by sex, all payers

  • Women37%
  • Men60%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Sreedhar A. Mandayam wrote 334 Medicare Part D claims in 2024

In 2024, Dr. Mandayam wrote 334 Medicare Part D claims for 65 patients. 78% of them were for generic drugs. CMS names the drug for 193 of them, across 8 drugs with 11 or more claims each, at $46,243 in total drug cost. In 2023, CMS named 124 claims across 6 drugs.

Part D claims, 2024334
Drugs named by CMS8
Total drug cost$46,243
Part D patients65

Dr. Mandayam's Part D claims by kind of drug, 2024

  • Generic259 claims78%
  • Brand-name75 claims22%

Dr. Mandayam's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1242024: 19356%

Drugs named by CMS: 8 in 2024, 6 in 2023.

See all prescribing by Dr. Mandayam

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Sreedhar A. Mandayam offers telehealth to Medicare patients

Dr. Mandayam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mandayam as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find nephrologists like Dr. Mandayam by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Sreedhar A. Mandayam has 45 publications on record

Dmand AI links 45 papers to Dr. Mandayam, published from 2007 to 2025. 2017 was the busiest year, with 10. The most frequent topics are Renal Insufficiency, Chronic, Kidney Failure, Chronic and Renal Dialysis. Dr. Mandayam has published most often in Am J Kidney Dis. Dr. Mandayam's most frequent co-authors are Wolfgang C. Winkelmayer, DSC, MD, Chandan Vangala, MD and Sankar Dass Navaneethan, MD.

Papers45
Years published2007 to 2025

Dr. Mandayam's papers by year, 2015 to 2025

Topics Dr. Mandayam writes about most

  • Renal Insufficiency, Chronic
  • Kidney Failure, Chronic
  • Renal Dialysis
  • Acute Kidney Injury
  • Nicaragua
  • Kidney
  • Nephritis, Interstitial
  • Agricultural Workers' Diseases

Dr. Mandayam's most frequent co-authors

Recent publications by Dr. Mandayam

See all 45 publications and co-authors

See who Dr. Mandayam researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Mandayam works with, so you can find a warm path to the right nephrologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Sreedhar A. Mandayam has worked on 5 clinical trials

Dmand AI links Dr. Mandayam to 5 clinical trials, 2 of them phase 4 studies. 4 are still active or recruiting. Conditions studied include Glomerulonephritis, IGA, Renal Insufficiency, Chronic and Kidney Failure, Chronic. Open Payments lists research payments to Dr. Mandayam that name 1 trial.

Clinical trials with Dr. Mandayam by phase

  1. NonePhase 1: no trials
  2. 1Phase 2: 1 trial
  3. 1Phase 3: 1 trial
  4. 2Phase 4: 2 trials

Conditions in Dr. Mandayam's trials

  • Glomerulonephritis, IGA
  • Renal Insufficiency, Chronic
  • Kidney Failure, Chronic
  • Nephritis, Hereditary
  • Tumor Lysis Syndrome

Investigators on the most trials with Dr. Mandayam

Recent clinical trials with Dr. Mandayam

Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Sreedhar A. Mandayam received $768,897 in industry payments from 2016 to 2025

CMS Open Payments shows 1,218 general payments to Dr. Mandayam from 51 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 45% of the total. Calliditas Therapeutics US Inc. paid the most, $222,145. It also lists 8 research payments totaling $125,579 from 2017 to 2023, naming 1 clinical trial.

General payments to Dr. Mandayam by program year, 2016 to 2025

General payments to Dr. Mandayam by kind, 2016 to 2025

$768.9Kin total
  • Speaker and faculty fees$346,15845%
  • Honoraria$207,30427%
  • Travel and lodging$93,64312%
  • Consulting fees$81,73111%
  • Other$40,0625%

Companies that paid Dr. Mandayam the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Mandayam

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Sreedhar A. Mandayam has 1 award and honors on record

Dmand AI lists 1 award for Dr. Mandayam, most recently CMS Stage 1 EHR in 2013.

Awards and honors for Dr. Mandayam

  1. 2013
    • CMS Stage 1 EHR

Source: Dmand AI Professional Profile Data

Dr. Sreedhar A. Mandayam graduated from Bangalore Medical College

Dr. Mandayam graduated from Bangalore Medical College in 1995. Dr. Mandayam is a member of ACP.

  1. Medical schoolBangalore Medical College
  2. Board certified in internal medicineAmerican Board of Internal Medicine
  3. Board certified in nephrologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Sreedhar A. Mandayam accepts plans from 14 insurance carriers

Dr. Mandayam is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.

  • Aetna
  • Blue Cross Blue Shield of Michigan
  • United Healthcare
  • Elevance
  • HCSC
  • Blue Cross Blue Shield of Massachusetts
  • Regence Health Plans
  • Alliant Health Plans
  • +6 more carriersWith a free account

Plan types Dr. Mandayam accepts, by number of carriers

  1. PPO9
  2. HMO7
  3. Medicare7
  4. POS4
  5. EPO3

Source: Dmand AI Insurance Network Data

Sources for Dr. Sreedhar A. Mandayam's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Sreedhar A. Mandayam

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Sreedhar A. Mandayam's NPI number?

Dr. Sreedhar A. Mandayam's NPI number is 1225051048. It was assigned on July 25, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Sreedhar A. Mandayam?

Dr. Sreedhar A. Mandayam is a nephrologist in Houston, Texas. The primary specialty in the NPI Registry is Nephrology Physician (taxonomy code 207RN0300X).

Where does Dr. Sreedhar A. Mandayam practice?

Dr. Mandayam practices at 1515 Holcombe Blvd, Houston, TX 77030. Dr. Mandayam's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. Dmand AI also links Dr. Mandayam to 2 medical groups.

What is Dr. Sreedhar A. Mandayam's medical license number?

Dr. Mandayam's Texas license number on file is N3861, one of the licenses on file in 10 states.

Which states has Dr. Sreedhar A. Mandayam been licensed in?

Dmand AI has state licenses on file for Dr. Mandayam in Texas (2009 to 2025), Florida (since 2021), Tennessee (2023 to 2027), Mississippi (2024 to 2026), Oklahoma (2020 to 2026), Washington (2023 to 2026), Alabama (2024 to 2025), Arizona (2023 to 2025), Georgia (2024 to 2025) and Louisiana (2023 to 2025).

Which hospitals is Dr. Sreedhar A. Mandayam affiliated with?

Dr. Mandayam practices at The University of Texas MD Anderson Cancer Center in Houston, Texas.

What medical group is Dr. Sreedhar A. Mandayam part of?

Dr. Mandayam is linked to Physicians Referral Service. Dmand AI links Dr. Mandayam to 2 more medical groups.

Does Dr. Sreedhar A. Mandayam accept Medicare?

Yes. CMS data shows Dr. Mandayam billed Medicare for 792 services in 2024, and Dr. Mandayam accepts Medicare assignment.

Does Dr. Sreedhar A. Mandayam offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Mandayam as offering telehealth services.

How many Medicare patients does Dr. Sreedhar A. Mandayam see?

CMS counts 345 Medicare patients who saw Dr. Mandayam in 2024, with an average age of 71.

Show 9 more questionsShow fewer questions

Is Dr. Sreedhar A. Mandayam board certified?

Yes. Dr. Mandayam is board certified in internal medicine by the American Board of Internal Medicine.

What services does Dr. Sreedhar A. Mandayam bill to Medicare?

In 2024, Dr. Mandayam's most billed Medicare services were hospital inpatient care (99233), hospital inpatient care (99223) and critical care (99291).

Where did Dr. Sreedhar A. Mandayam go to medical school?

Dr. Mandayam graduated from Bangalore Medical College in 1995.

What drugs does Dr. Sreedhar A. Mandayam prescribe most?

In 2024 Medicare Part D data, Dr. Mandayam's most prescribed drugs by claims were Allopurinol, Jardiance and Furosemide.

Has Dr. Sreedhar A. Mandayam received payments from drug or device companies?

CMS Open Payments shows $768,897 in general payments to Dr. Mandayam from 51 companies from 2016 to 2025. The largest total came from Calliditas Therapeutics US Inc.

How long has Dr. Sreedhar A. Mandayam been practicing?

Dr. Mandayam graduated from medical school in 1995, 31 years ago.

Does Dr. Sreedhar A. Mandayam do research?

Dmand AI links 45 publications to Dr. Mandayam, published from 2007 to 2025. Dr. Mandayam has worked on 5 clinical trials.

Who does Dr. Sreedhar A. Mandayam publish with?

Dr. Mandayam's most frequent co-authors are Wolfgang C. Winkelmayer, DSC, MD (10 shared papers), Chandan Vangala, MD (8 shared papers) and Sankar Dass Navaneethan, MD (4 shared papers).

What insurance does Dr. Sreedhar A. Mandayam accept?

Dr. Mandayam is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.

Selling to nephrology practices?

See nephrologists in Texas by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)